Host defence (cationic) peptides: what is their future clinical potential?
about
Candidacidal activities of human lactoferrin peptides derived from the N terminusInteraction of acylated and substituted antimicrobial peptide analogs with phospholipid-polydiacetylene vesicles. Correlation with their biological properties.Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranesMultivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural DiversitiesReducing mortality in Salmonella enterica serovar Typhimurium-infected mice with a tripeptidic serum fraction.Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.Burkholderia is highly resistant to human Beta-defensin 3.Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications.Iterative antimicrobial candidate selection from informed d-/l-Peptide dimer libraries.Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides.Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides.The role of defensins in lung biology and therapy.Length effects in antimicrobial peptides of the (RW)n seriesStrand length-dependent antimicrobial activity and membrane-active mechanism of arginine- and valine-rich β-hairpin-like antimicrobial peptides.Structure and Bioactivity of a Modified Peptide Derived from the LPS-Binding Domain of an Anti-Lipopolysaccharide Factor (ALF) of Shrimp.On the physiology and pathophysiology of antimicrobial peptides.The dlt operon of Bacillus cereus is required for resistance to cationic antimicrobial peptides and for virulence in insects.Dermaseptins and magainins: antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review.De novo design of potent antimicrobial peptidesS. Typhimurium strategies to resist killing by cationic antimicrobial peptides.Cationic hydrophobic peptides with antimicrobial activityAntimicrobial activity, biocompatibility and hydrogelation ability of dipeptide-based amphiphiles.Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3).Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study.An investigation into the biological activity of the selected histidine-containing diketopiperazines cyclo(His-Phe) and cyclo(His-Tyr).THE BIOFILM CONCEPT: CONSEQUENCES FOR FUTURE PROPHYLAXIS OF ORAL DISEASES?Epidermoid carcinoma-derived antimicrobial peptide (ECAP) inhibits phosphorylation by protein kinases in vitro.The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitisAntimicrobial peptide-lipid binding interactions and binding selectivity.Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations.Intracellular biomass flocculation as a key mechanism of rapid bacterial killing by cationic, amphipathic antimicrobial peptides and peptoids.Structural requirements for antimicrobial versus chemoattractant activities for dermaseptin S9.Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.Optimization of the antimicrobial activity of magainin peptides by modification of charge.Concentration-Dependent Mechanism Alteration of Pleurocidin Peptide in Escherichia coli.
P2860
Q24290527-C9162E8E-7DCE-48E1-AE42-E4B4D6084992Q33874244-CA35B74A-408E-4D46-859A-747D4040A81EQ34017067-8A616277-36C1-44FB-BB7A-FAB967147A99Q34098551-E98F3915-3582-4A6A-AC89-3A5671D4CD04Q34108463-E2D1030F-0F99-4265-9E65-D434CAC4B620Q34346351-FF4D8667-265C-43B7-ACAC-B73E176D0BBCQ34941575-EE2C37CD-0BC6-4309-B88A-0F3C8CBB8E7AQ34973666-9A3FD7F6-873B-4CDF-919F-057FC664FCD8Q35024514-CE14B8E8-C3A2-45F2-84FF-BECEF68AB42CQ35143890-FA727C7D-D535-41FC-BD43-0A6F0F04981EQ35217549-1BE5A7A1-A286-4330-A7EC-DA245BB4E583Q35627809-FFFB70C0-456B-437C-B17C-154575687A9EQ35636002-46B89FA1-090A-48E2-99F2-83497EDAC211Q36018919-B655CF26-243F-42A3-9AAE-9CBE60AFDBFEQ36941480-777E89C3-06F0-47CC-A68E-8021D3769BE2Q37327972-39728EB7-3A8E-450F-B60E-771AEFB0C610Q37410213-F9073E79-2559-4F4A-895E-DB6A3735EA68Q37412040-5218B281-E080-4B53-A990-2CBF04C26606Q37489546-F430AAC7-65E8-4D98-83F0-8A73F7D30254Q38341710-519A5B85-8A02-4DEA-A424-7DAEAF44717AQ39657941-3C9874E1-37A3-46F8-B057-33D8B6CA5A6BQ39905343-3E82771F-8D71-4235-AD1B-BAFC383FA47EQ40139526-90A1FE1C-3AFC-40A6-B871-FBB66DC188C5Q40172265-A1E5234B-AB64-417E-9198-DB8D43E4036BQ40523331-F05934A3-6E70-4C95-83E0-1AD0FD7F8CACQ40533381-4F7CF5BD-FE7C-44AF-B0A7-12B784133C66Q40762975-EDC72215-DA6F-400A-9981-1C408F2078B7Q41770407-E9B5C69E-67D5-4563-96A1-9B9E48161DDCQ41907657-D48B7E4E-925A-4C32-95B0-88CC29F1DAB8Q42255683-36228B0C-1FE8-4DE4-B232-85F3EAFC6D2AQ46011239-A178A4FE-64A5-4760-B26E-E79EC116B134Q46476356-42093C56-6D6A-4D91-A36F-649C35E78C89Q52898669-4A032CCB-7A18-4409-B9E2-3BE200E981ADQ52963013-4BA866E5-1942-4F0E-976A-086F679AB3DBQ54256938-5C717ED3-BA68-446D-8C05-D89129650458
P2860
Host defence (cationic) peptides: what is their future clinical potential?
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Host defence (cationic) peptides: what is their future clinical potential?
@ast
Host defence (cationic) peptides: what is their future clinical potential?
@en
type
label
Host defence (cationic) peptides: what is their future clinical potential?
@ast
Host defence (cationic) peptides: what is their future clinical potential?
@en
prefLabel
Host defence (cationic) peptides: what is their future clinical potential?
@ast
Host defence (cationic) peptides: what is their future clinical potential?
@en
P1433
P1476
Host defence (cationic) peptides: what is their future clinical potential?
@en
P2093
Hancock RE
P304
P356
10.2165/00003495-199957040-00002
P577
1999-04-01T00:00:00Z
P6179
1021120870